- Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
-
Tsai YN, Wu JL, Hsu YC
- KMID: 2554436
- Clin Mol Hepatol.
- 2024 Apr;30(2):276-278.
- doi: 10.3350/cmh.2024.0220
-
- CITED
-
- Close
- SHARE
-
- Close
- Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring
-
Tsai YN, Wu JL, Hsu YC
- KMID: 2554442
- Clin Mol Hepatol.
- 2024 Apr;30(2):293-296.
- doi: 10.3350/cmh.2024.0101
-
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation
-
Tsai YN, Wu JL, Tseng CH, Chen TH, Wu YL, Chen CC, Fang YJ, Yang TH, Nguyen MH, Lin JT, Hsu YC
- KMID: 2549386
- Clin Mol Hepatol.
- 2024 Jan;30(1):98-108.
- doi: 10.3350/cmh.2023.0194
Background/Aims: Finite nucleos(t)ide analog (NA) therapy has been proposed as an alternative treatment strategy for chronic hepatitis B (CHB), but biomarkers for post-treatment monitoring are limited. We investigated whether measuring... -
- CITED
-
- Close
- SHARE
-
- Close
